Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,007
Closed -$504K 478
2025
Q4
$504K Buy
4,007
+1,066
+36% +$139K 0.05% 168
2025
Q3
$430K Sell
2,941
-20
-0.7% -$3.02K 0.05% 251
2025
Q2
$462K Buy
2,961
+594
+25% +$94.2K 0.05% 190
2025
Q1
$390K Buy
2,367
+289
+14% +$48.1K 0.05% 165
2024
Q4
$339K Sell
2,078
-422
-17% -$75.5K 0.05% 175
2024
Q3
$488K Sell
2,500
-198
-7% -$36.5K 0.07% 157
2024
Q2
$468K Buy
2,698
+303
+13% +$50.4K 0.08% 150
2024
Q1
$405K Sell
2,395
-1,665
-41% -$312K 0.07% 139
2023
Q4
$801K Buy
4,060
+573
+16% +$101K 0.14% 103
2023
Q3
$607K Sell
3,487
-4
-0.1% -$726 0.19% 102
2023
Q2
$601K Buy
+3,491
New +$604K 0.18% 99
2020
Q2
Sell
-6,787
Closed -$799K 66
2020
Q1
$799K Sell
6,787
-1,198
-15% -$158K 0.57% 26
2019
Q4
$1.06M Hold
7,985
0.56% 15
2019
Q3
$995K Sell
7,985
-2,824
-26% -$341K 0.54% 14
2019
Q2
$1.23M Buy
+10,809
New +$1.13M 0.56% 15

Other funds holding ZTS

Cynosure Group's ZTS Position: Q1 2026 in Review

Cynosure Group sold out of Zoetis (ZTS) in Q1 2026, closing a stake of 4,007 shares — an estimated $504K sold.

Cynosure Group first reported a position in ZTS in Q2 2019 and held it in 15 quarters. The position peaked at $1.23M in Q2 2019. 1,605 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • Cynosure Group reported no remaining Zoetis position as of Q1 2026 after selling out during the quarter.
  • Cynosure Group sold 4,007 Zoetis shares in Q1 2026, an estimated $504K.
  • Cynosure Group first reported a position in Zoetis in Q2 2019 and held it in 15 quarters.
  • Cynosure Group's Zoetis position peaked at $1.23M in Q2 2019.
  • 1,605 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on Cynosure Group's 13F filing for Q1 2026, filed 14 May 2026.